Seminars in Diagnostic Pathology
Volume 23, Issue 1 , Pages 44-55 , February 2006

Spindle cell tumors of the pleura: differential diagnosis

  • Monica Rdzanek, MD

      Affiliations

    • Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University, Maywood, Illinois
    • ,
  • Raoul Fresco, MD, PhD

      Affiliations

    • Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University, Maywood, Illinois
    • ,
  • Harvey I. Pass, MD

      Affiliations

    • Department of Thoracic Surgery, New York University, New York, New York.
    • ,
  • Michele Carbone, MD

      Affiliations

    • Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University, Maywood, Illinois
    • Corresponding Author InformationAddress reprint requests and correspondence: Michele Carbone, MD, PhD, Thoracic Oncology Program, Cancer Center of Hawaii, University of Hawaii, 651 Ilalo Street, BSB Room 228, Honolulu, HI 96813.

References 

  1. Crotty R . Localised malignant mesothelioma, a clinicopathologic and flow cytometric study . Am J Surg Pathol . 1994;18:357–363
  2. Mangano W , Cagle P , Churg A , et al.   The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy . Am J Clin Pathol . 1998;110:191–199
  3. Miettinen M . Soft tissue tumors with epithelial differentiation . In:  Miettinin M editors. Soft Tissue Tumors . Philadelphia, PA: Churchill Livingstone; 2003;p. 463–487
  4. Carbone M , Rizzo P , Powers A , et al.   Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesothelioma: clinical implications . Anticancer Res . 2002;22:3443–3448
  5. Gladish G , Sabloff B , Munden R , et al.   Primary thoracic sarcomas . Radiographics . 2002;22:621–637
  6. Moran C , Travis W , Rosado-de-Christenson M , et al.   Thymomas presenting as pleural tumors (Report of eight cases) . Am J Surg Pathol . 1992;16:138–144
  7. Ordonez  , Nelson G . The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study . Hum Pathol . 2004;35:697–710
  8. Attanoos RL , Dojcinov SD , Webb R , et al.   Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms . Histopathology . 2000;37:224–231
  9. Powers A , Carbone M . Diagnosis of synovial sarcoma of the pleura and differentiation from malignant mesothelioma . In:  Pass H ,  Vogelzang N ,  Carbone M editor. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies . New York, NY: Springer Science and Business Media; 2005;p. 543–554
  10. Miettinen M . Neuroectodermal and neural tumors . In:  Miettinen M editors. Soft Tissue Tumors . Philadelphia, PA: Churchill Livingstone; 2003;p. 379–402
  11. Giordano GG , Nappi O . Benign mesotheliomas, mesothelial proliferations, and their possible association with asbestos exposure . In:  Pass H ,  Vogelzang N ,  Carbone M editor. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies . New York, NY: Springer Science and Business Media; 2005;p. 469–480
  12. Battifora H , McCaughey WT . In: Atlas of Tumor Pathology: Tumors of the Serosal Membranes . Wahington, DC: AFIP (Armed Forces Institute of Pathology); 1995;p. 37–66
  13. Guine DG , Travis WD . Pitfalls in the diagnosis of malignant mesothelioma . In:  Pass H ,  Vogelzang N ,  Carbone M editor. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies . New York, NY: Springer Science and Business Media; 2005;p. 555–580
  14. Kim O , Krausz T . Differentiating sarcomas from mesotheliomas . In:  Pass H ,  Vogelzang N ,  Carbone M editor. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies . New York, NY: Springer Science and Business Media; 2005;p. 527–542
  15. Lucas DR , Pass HI , Madan K , et al.   Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study . Histopathology . 2003;42:270–279
  16. Gonzalez-Louis C , Ballestin C , Sotelo MT , et al.   Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura . Histopathology . 2001;38:528–534
  17. Kayser K , Bohm G , Blum S , et al.   Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients . J Pathol . 2001;193:175–180
  18. Pier-Giacomo B . Immunohistochemistry . In:  Pass H ,  Vogelzang N ,  Carbone M editor. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies . New York, NY: Springer Science and Business Media; 2005;p. 490–507
  19. Hurtek MG , Carbone M . A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma . Anticancer Res . 2004;24:3097–3102
  20. Lewis JS , Ritter JH , El-Mofty S . Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder- p63, MOC-31, and TTF-1 . Mod Pathol . 2005;18:1471–1481
  21. Miettinen M , Sarlomo-Rikala M . Expression of calretinin, thrombomodulin, keratin 5 and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura . Am J Surg Pathol . 2003;27:150–158
  22. Miettinen M , Limon J , Niezabitowski A , et al.   Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma . Am J Surg Pathol . 2001;25:610–617
  23. Osborn M , Pelling N , Walker MM , et al.   The value of ‘mesothelium-associated’ antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas . Histopathology . 2002;41:301–307
  24. Miettinen M . Smooth muscle tumors . In:  Miettinen M editors. Soft Tissue Tumors . Philadelphia, PA: Churchill Livingstone; 2003;p. 241–258
  25. Wiebe T , Wetzker K . Pulmonary and pleural metastases in malignant melanoma . Z Erkr Atmungsorgane . 1986;167:145–151
  26. Rasmussen OO , Larsen KE . S-100 protein in malignant mesotheliomas . Acta Pathol Microbiol Immunol Scand . 1985;93:199–201
  27. Pan C , Chen P , Chou T , et al.   Expression of calretinin and other mesothelioma related markers in thymic carcinoma and thymoma . Hum Pathol . 2003;34:1155–1162
  28. Kobayashi TK , Teraoka S , Tsujioka T , et al.   Ciliated ovarian adenocarcinoma cells in ascetic fluid cytology: report of a case with immunocytochemical features . Diagn Cytopathol . 1988;4:234–238
  29. Oury TD , Hammar SP , Roggli VL . Ultrastructural features of diffuse malignant mesotheliomas . Hum Pathol . 1998;29:1382–1392
  30. Dvorak AM , Monahan-Earley RA . Case 32: thymoma . In:  Dvorak AM ,  Monahan-Earley RA editor. Diagnostic Ultrastructural Pathology. I. A Text-Atlas of Case Studies Illustrating the Correlative Clinical-Ultrastructural Pathologic Approach to Diagnosis . Boca Raton, FL: CRC Press; 1992;p. 274–284
  31. Dvorak AM , Monahan-Earley RA . Case 44: melanoma metastatic to lung . In:  Dvorak AM ,  Monahan-Earley RA editor. Diagnostic Ultrastructural Pathology. I. A Text-Atlas of Case Studies Illustrating the Correlative Clinical-Ultrastructural Pathologic Approach to Diagnosis . Boca Raton, FL: CRC Press; 1992;p. 379–401
  32. Dvorak AM , Monahan-Earley RA . Case 50: renal cell carcinoma metastatic to lung . In:  Dvorak AM ,  Monahan-Earley RA editor. Diagnostic Ultrastructural Pathology. I. A Text-Atlas of Case Studies Illustrating the Correlative Clinical-Ultrastructural Pathologic Approach to Diagnosis . Boca Raton, FL: CRC Press; 1992;p. 444–461
  33. Ordonez NG , Mackay B . Glycogen-rich mesothelioma . Ultrastruct Pathol . 1999;23:401–406
  34. Dvorak AM , Monahan-Earley RA . Case 48: fibrosarcoma . In:  Dvorak AM ,  Monahan-Earley RA editor. Diagnostic Ultrastructural Pathology. I. A Text-Atlas of 26 Case Studies Illustrating the Correlative Clinical-Ultrastructural Pathologic Approach to Diagnosis . Boca Raton, FL: CRC Press; 1992;p. 432–435
  35. Dvorak AM , Monahan-Earley RA . Case 51- Leiomyosarcoma of the uterus metastatic to lung . In:  Dvorak AM ,  Monahan-Earley RA editor. Diagnostic Ultrastructural Pathology. I: A Text-Atlas of Case Studies Illustrating the Correlative Clinical-Ultrastructural Pathologic Approach to Diagnosis . Boca Raton, Florida: CRC Press, Inc; 1992;p. 462–471
  36. Delattre O , Zucman J , Plougastel B , et al.   Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours . Nature . 1982;359:162–165
  37. Knezevich S , McFadden D , Wen T , et al.   A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma . Nat Genet . 1998;18:184–187
  38. Schoenmakers E , Huysmans C , Van de Ven W . Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas . Cancer Res . 1999;59:19–23
  39. Panagopoulos I , Hoglund M , Mertens F , et al.   Fusion of the EWS and CHOP genes in myxoid liposarcoma . Oncogene . 1996;12:489–494
  40. Sidhar SK , Clark J , Gill S , et al.   The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene . Hum Mol Genet . 1996;5:1333–1338
  41. Crew J , Clark J , Fisher C , et al.   Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma . EMBO J . 1995;14:2333–2340
  42. Mancuso T , Mezzelani A , Riva C , et al.   Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma . Lab Invest . 2000;80:805–813
  43. Apostolou S , Balsara BR , Testa JR . Cytogenetics of malignant mesothelioma . In:  Pass H ,  Vogelzang N ,  Carbone M editor. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies . New York, NY: Springer Science and Business Media; 2005;p. 101–111
  44. Nilsson G , Skytting B , Zie Y , et al.   The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome . Cancer Res . 1999;59:3180–3184
  45. Kawai A , Woodruff J , Healey JF , et al.   SYT-SSX1 fusion as a determinant of morphology and prognosis in synovial sarcoma . N Engl J Med . 1998;338:153–160

PII: S0740-2570(06)00085-2

doi: 10.1053/j.semdp.2006.06.002

Seminars in Diagnostic Pathology
Volume 23, Issue 1 , Pages 44-55 , February 2006

Article Tools

* Image Usage & Resolution